但是一个不同寻常的利益冲突意味着制药公司基因泰克对此格外地沉默。
But an unusual conflict of interest means that Genentech, the drug company that produces Lucentis, is conspicuously silent.
相对于其它抗癌治疗，价格也反映了基因泰克公司对药品的感知价值。
The price also reflected Genentech's perceived value of the drug compared with other cancer treatments.
六月份，雅培公司和基因泰克公司宣布，两公司将运用这种方法合作开发一种抗癌药。
In June, Abbott Laboratories Inc. and Genentech said they would collaborate to develop a cancer drug using this approach.
应用推荐